HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2005.09.030v1 47/3/598    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Herrero, P. Articles by Gropler, R. J. Search for Related Content PubMed PubMed Citation Articles by Herrero, P. Articles by Gropler, R. J.

CLINICAL RESEARCH: DIABETES AND OBESITY

Increased Myocardial Fatty Acid Metabolism in Patients With Type 1 Diabetes Mellitus

Pilar Herrero, MS^_*, Linda R. Peterson, MD^,, Janet B. McGill, MD, Stanley Matthew, MD, Donna Lesniak, RN^_*, Carmen Dence, MS^_* and Robert J. Gropler, MD^_*,,_*

^_* Division of Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri
Division of Geriatrics and Nutritional Sciences, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Division of Endocrinology and Metabolism, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Manuscript received January 11, 2005; revised manuscript received August 15, 2005, accepted September 12, 2005.

^_* Reprint requests and correspondence: Dr. Robert J. Gropler, Cardiovascular Imaging Laboratory, Mallinckrodt Institute of Radiology, 510 South Kingshighway, St. Louis, Missouri 63110 (Email: Groplerr{at}mir.wustl.edu).

OBJECTIVES: The purpose of this study was to determine if myocardial fatty acid utilization (MFAU) and myocardial fatty acid oxidation (MFAO) are increased in diabetic patients.

BACKGROUND: Experimental models of diabetes mellitus demonstrate that MFAU and MFAO are increased, and that this dependence on myocardial fatty acid metabolism may be detrimental to cardiac function. Whether similar metabolic changes occur in humans with diabetes mellitus is unclear.

METHODS: Eleven healthy non-diabetic control patients (5 women, ages 25 ± 5 years) and 11 otherwise healthy patients with type 1 diabetes mellitus (T1DM) (8 women, ages 36 ± 10 years, HbA1c 8.4 ± 1.9%) underwent positron emission tomography for the determination of myocardial blood flow (MBF); myocardial oxygen consumption (MVO₂); myocardial glucose utilization (MGU); and MFAU, MFAO, and %MFAO.

RESULTS: Plasma lactate, insulin, and MBF levels were similar between the two groups. However, plasma glucose (5.71 ± 0.98 µmol/ml vs. 5.28 ± 0.65 µmol/ml, p = 0.04), free fatty acid levels (0.60 ± 0.24 µmol/ml vs. 0.19 ± 0.07 µmol/ml, p < 0.0001), and MVO₂ (6.64 ± 2.21 vs. 4.51 ± 1.39 µmol/g/min, p = 0.007) levels were higher in the T1DM subjects. Furthermore, compared with control patients, T1DM subjects exhibited higher MFAU (213 ± 135 nmol/g/min vs. 57 ± 28 nmol/g/min, p = 0.0004), MFAO (206 ± 131 nmol/g/min s. 50 ± 26 nmol/g/min, p = 0.0002), and %MFAO (94 ± 6% vs. 81 ± 19%, respectively, p = 0.04). In contrast, MGU was lower in T1DM subjects than in controls (207 ± 108 nmol/g/min vs. 403 ± 191 nmol/g/min, p = 0.0008).

CONCLUSIONS: Humans with diabetes mellitus exhibit increased MFAU and MFAO and reduced MGU consistent with observations obtained in experimental models of diabetes.

Abbreviations and Acronyms   FFA = free fatty acid   MBF = myocardial blood flow (ml/g/min)   MFAEF = myocardial fatty acid extraction fraction   MFAO = myocardial fatty acid oxidation (nmol/g/min)   MFAU = myocardial fatty acid utilization (nmol/g/min)   MGEF = myocardial glucose extraction fraction   MGU = myocardial glucose utilization (nmol/g/min)   MVO2 = myocardial oxygen consumption (µmol/g/min)   PET = positron emission tomography   PPAR = peroxisome proliferator-activated receptor   T1DM/T2DM = type 1 diabetes mellitus/type 2 diabetes mellitus

This article has been cited by other articles:

				L. R. Peterson, P. Herrero, J. McGill, K. B. Schechtman, Z. Kisrieva-Ware, D. Lesniak, and R. J. Gropler Fatty Acids and Insulin Modulate Myocardial Substrate Metabolism in Humans With Type 1 Diabetes Diabetes, January 1, 2008; 57(1): 32 - 40. [Abstract] [Full Text] [PDF]

				P. Herrero, C. S. Dence, A. R. Coggan, Z. Kisrieva-Ware, P. Eisenbeis, and R. J. Gropler L-3-11C-Lactate as a PET Tracer of Myocardial Lactate Metabolism: A Feasibility Study J. Nucl. Med., December 1, 2007; 48(12): 2046 - 2055. [Abstract] [Full Text] [PDF]

				S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023. [Abstract] [Full Text] [PDF]

				M. P. Chandler, E. E. Morgan, T. A. McElfresh, T. A. Kung, J. H. Rennison, B. D. Hoit, and M. E. Young Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1609 - H1616. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley Cardiac Energy Metabolism in Obesity Circ. Res., August 17, 2007; 101(4): 335 - 347. [Abstract] [Full Text] [PDF]

				S. Boudina and E. D. Abel Diabetic Cardiomyopathy Revisited Circulation, June 26, 2007; 115(25): 3213 - 3223. [Abstract] [Full Text] [PDF]

				L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass Eur. Heart J., March 1, 2007; 28(5): 553 - 559. [Abstract] [Full Text] [PDF]

				S. Boudina and E. D. Abel Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology, August 1, 2006; 21: 250 - 258. [Abstract] [Full Text] [PDF]

				M. J. Welch, J. S. Lewis, J. Kim, T. L. Sharp, C. S. Dence, R. J. Gropler, and P. Herrero Assessment of Myocardial Metabolism in Diabetic Rats Using Small-Animal PET: A Feasibility Study J. Nucl. Med., April 1, 2006; 47(4): 689 - 697. [Abstract] [Full Text] [PDF]